Piroxicam-induced analgesia: evidence for a central component which is not opioid mediated.
Piroxicam is a nonsteroidal anti-inflammatory drug with a potent analgesic effect. In order to establish whether the analgesic action of Piroxicam has a central component, we studied the effect of the drug on the nociceptive orbicularis oculi reflexes evoked by electrical stimulation of the cornea and supraorbital nerve in healthy subjects. Piroxicam significantly suppressed the corneal reflex and R3 component of the blink reflex by 28% (p < 0.05) and 50% (p < 0.01), respectively. This effect was not reversed by the i.v. injection of naloxone. Beta-endorphin levels did not change. Piroxicam administration induces distinct inhibitory changes in nociceptive reflexes, which suggests that the analgesic action of the drug has a central component. The ineffectiveness of naloxone, and the lack of beta-endorphin changes, indicate that this central action is independent of the opioid system; other pain regulatory systems are probably involved.
Fabbri
A
A
Chair of Andrology, Vth Medical Clinic, Rome, Italy.
Cruccu
G
G
Sperti
P
P
Ridolfi
M
M
Ciampani
T
T
Leardi
M G
MG
Ferracuti
S
S
Bonifacio
V
V
D000328:Adult; D001767:Blinking / Q000187:drug effects; D003315:Cornea / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D009270:Naloxone / Q000494:pharmacology; D010894:Piroxicam / Q000494:pharmacology*; D010919:Placebos; D012018:Reflex / Q000187:drug effects*; D016037:Single-Blind Method; D001615:beta-Endorphin / Q000378:metabolism*
D010919:Placebos; D010894:Piroxicam; D009270:Naloxone; D001615:beta-Endorphin